Amnesia – Pipeline Review, H1 2012 Aarkstore.com announces, The Latest market research report is available in its vast collection: RSS link of Global Markets Direct http://www.aarkstore.com/feeds/Global-Markets-Direct.xml Summary Global Markets Direct’s, Amnesia - Pipeline Review, H1 2012, provides an overview of the Amnesia therapeutic pipeline. This report provides information on the therapeutic development for Amnesia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Amnesia. Amnesia - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for Amnesia. - A review of the Amnesia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Amnesia pipeline on the basis of route of administration and molecule type. Amnesia – Pipeline Review, H1 2012 Table of contents: 2 List of Tables 3 List of Figures 3 Introduction 4 Global Markets Direct Report Coverage 4 Amnesia Overview 5 Therapeutics Development 6 An Overview of Pipeline Products for Amnesia 6 Amnesia Therapeutics under Investigation by Universities/Institutes 8 Mid Clinical Stage Products 9 Comparative Analysis 9 Amnesia Therapeutics – Products under Investigation by Universities/Institutes 10 Amnesia – Therapeutics Assessment 11 Assessment by Monotherapy Products 11 Assessment by Route of Administration 12 Assessment by Molecule Type 14 Drug Profiles 16 Rosuvastatin - Drug Profile 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Midazolam Hydrochloride - Drug Profile 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Midazolam - Drug Profile 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Amnesia Therapeutics - Dormant Products 19 Appendix 20 List of Figures Amnesia – Pipeline Review, H1 2012 List of Tables are also include. For more related Reports Plz follow The link: Pipeline Review, H1 2012 http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1 Gastritis – Pipeline Review, H1 2012 Amnesia – Pipeline Review, H1 2012 Primary Biliary Cirrhosis – Pipeline Review, H1 2012 Congenital Heart Disease – Pipeline Review, H1 2012 Emphysema – Pipeline Review, H1 2012 Hyperphosphatemia In Chronic Kidney Disease – Pipeline Review, H1 2012 Pheochromocytoma – Pipeline Review, H1 2012 Neuralgia – Pipeline Review, H1 2012 Thromboembolism – Pipeline Review, H1 2012 Obsessive-Compulsive Disorder – Pipeline Review, H1 2012 Bone Cancer – Pipeline Review, H1 2012 Status Epilepticus – Pipeline Review, H1 2012 Amnesia – Pipeline Review, H1 2012 Thrombocythaemia Myelofibrosis – Pipeline Review, H1 2012 Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 For More details Plz do contact : Aarkstore Enterprise Lavanya Phone:08149852585 Email: firstname.lastname@example.org
"2012 || Pharmaceuticals and Healthcare || Amnesia – Pipeline Review, H1 2012 || Aarkstore.com"